Background Immune responses after influenza immunization are reduced in elderly
individuals, the group at greatest risk for complications and death after influenza. Improved …

Deans GD, Stiver HG, McElhaney JE (University of British Columbia, Vancouver, Canada).
Influenza vaccines provide diminished protection but are cost‐saving in older adults …

Healthy ambulatory elderly were immunized with increasing doses of the 1984–1985
influenza vaccine formulation. Two types of vaccines, split‐product vaccine (SPV) and whole …

Background Vaccination rates for healthy senior citizens are lower than those for senior
citizens with underlying medical conditions such as chronic heart or lung disease …

Background Influenza vaccination of elderly individuals (65 years or older) has been
recommended in the United States since 1961, and consistent surveillance of vaccine use …

Objective.—To determine the efficacy of influenza vaccination in elderly people. Design.—
Randomized double-blind placebo-controlled trial. Setting.—Fifteen family practices in the …

Background Influenza vaccination has consistently been shown to prevent all-cause death
and hospitalizations during influenza epidemics among seniors. However, such benefits …

Although a number of studies have investigated and quantified immune correlates of
protection against influenza in adults and children, data on immune protection in the elderly …

To improve immune responses to influenza vaccine, a trivalent inactivated vaccine
containing 60μg of the HA of each component (A/H3N2, A/H1N1, B) was compared to a …

Concern about side effects constitutes a major deterrent to patient compliance with influenza
vaccination, yet there is a paucity of data about the occurrence of adverse reactions in the …